 Home > Medical News > Latest Medical News > FDA Accepts Precision Therapeutics New Drug Application for Certain Non-Small Cell Lung Cancers

FDA Accepts Precision Therapeutics New Drug Application for Certain Non-Small Cell Lung Cancers

 Last Update: 2022-03-07
 Source: Internet
 Author: User

Tags

il 2 function

topamax drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Spectrum Pharmaceuticals announced today that the U.

According to the World Health Organization (WHO), in 2020, lung cancer is the leading cause of cancer death worldwide

Due to its unique structure, Poziotinib has been shown in preclinical experiments to irreversibly bind to the HER2 receptor carrying exon 20 insertion mutations, inhibiting its function and kinase activity, thereby inhibiting cancer cell proliferation and leading to cancer cell death

▲ The mechanism of action of Poziotinib (Image source: Spectrum Pharmaceuticals' official website)

The FDA's acceptance of the NDA is based on positive results from a Phase 2 clinical trial

References:

[1] Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib.

(Original abridged)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.